The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy: Bone Marrow Transplantation

P. Ljungman, M. Mikulska, R. de la Camara, G.W. Basak, C. Chabannon, S. Corbacioglu, R. Duarte, H. Dolstra, A.C. Lankester, M. Mohty, S. Montoto, J. Murray, R. Peffault de Latour, J.A. Snowden, I. Yakoub-Agha, B. Verhouven, N. Kröger, J. Styczynski, for the European Society for Blood and Marrow Transplantation

Research output: Contribution to journalArticle

Abstract

The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease by WHO called COVID-19. This pandemic poses unprecedented stress on the health care system including programs performing allogeneic and autologous hematopoietic cell transplantation (HCT) and cellular therapy such as with CAR T cells. Risk factors for severe disease include age and predisposing conditions such as cancer. The true impact on stem cell transplant and CAR T-cell recipients in unknown. The European Society for Blood and Marrow Transplantation (EBMT) has therefore developed recommendations for transplant programs and physicians caring for these patients. These guidelines were developed by experts from the Infectious Diseases Working Party and have been endorsed by EBMT’s scientific council and board. This work intends to provide guidelines for transplant centers, management of transplant candidates and recipients, and donor issues until the COVID-19 pandemic has passed. © 2020, The Author(s).
Original languageEnglish
JournalBone Marrow Transplantation
DOIs
Publication statusPublished - 2020

Keywords

  • COVID19
  • ONCOLOGIA
  • STUDIO CLINICO
  • RIS

Fingerprint Dive into the research topics of 'The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy: Bone Marrow Transplantation'. Together they form a unique fingerprint.

  • Cite this

    Ljungman, P., Mikulska, M., de la Camara, R., Basak, G. W., Chabannon, C., Corbacioglu, S., Duarte, R., Dolstra, H., Lankester, A. C., Mohty, M., Montoto, S., Murray, J., Peffault de Latour, R., Snowden, J. A., Yakoub-Agha, I., Verhouven, B., Kröger, N., Styczynski, J., & Transplantation, F. T. E. S. F. B. A. M. (2020). The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy: Bone Marrow Transplantation. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-020-0919-0